A5102890539- Liver Disease Diagnosis and Treatment
- Liver Diseases and Immunity
- Organ Transplantation Techniques and Outcomes
- Gallbladder and Bile Duct Disorders
- Liver Disease and Transplantation
- Fibroblast Growth Factor Research
- Pancreatitis Pathology and Treatment
- Pediatric Hepatobiliary Diseases and Treatments
- Neurological Disorders and Treatments
- Muscle metabolism and nutrition
- Thermal Regulation in Medicine
- Systemic Sclerosis and Related Diseases
- Drug Transport and Resistance Mechanisms
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hormonal and reproductive studies
- HIV/AIDS drug development and treatment
- Anesthesia and Neurotoxicity Research
- Hepatitis B Virus Studies
- Alcohol Consumption and Health Effects
- Acute Ischemic Stroke Management
- Stroke Rehabilitation and Recovery
- Intensive Care Unit Cognitive Disorders
- Folate and B Vitamins Research
- Hepatitis C virus research
Universidade Federal da Bahia
2015-2024
Complexo Hospitalar Universitário Professor Edgard Santos
2024
National Council for Scientific and Technological Development
2021
Real Hospital Português
2015
Abstract Background Several HCV patients in Brazil were lost to follow-up (LTFU) the last two decades before achievement of sustained virological response (SVR). Strategies recall those diagnosed but untreated have been used elsewhere with different success rates. Aim To identify and retrieve LTFU order offer them treatment current highly effective direct acting antiviral agents (DAAs). Methods Registries ofall from three large reference centers retrospectively reviewed no registry SVR....
Background: The recreational use of anabolic-androgenic steroids (AAS) has reached alarming levels among healthy people. However, several complications have been related to consumption these drugs, including liver disorders. Objective: To evaluate the prevalence injuries in young Brazilian AAS users. Methods: Between February/2007 and May/2012 asymptomatic bodybuilders who were ≥18 years old reported for ≥6 months enrolled. All had clinical evaluations, abdominal ultrasound (AUS), blood...
Non-alcoholic fatty liver disease (NAFLD) is an emerging cause of graft dysfunction after transplantation (LT) frequently related to the development new onset diabetes LT (NODAT). This study was undertaken evaluate frequencies NODAT and NAFLD LT, investigate their major risk factors impact de novo or recurrent in function. 119 patients submitted were prospectively evaluated. After 4 ± 1 years, NODAT, observed 31%, 56% 43% subjects, respectively. Only 3 had non-alcoholic steatohepatitis...
ABSTRACT Survival rates of critically ill patients with liver disease has sharply increased in recent years due to several improvements the management decompensated cirrhosis and acute failure. This is ascribed incorporation evidence-based strategies from clinical trials aiming reduce mortality. In order discuss cutting-edge evidence regarding critical care disease, a joint single topic conference was recently sponsored by Brazilian Society Hepatology cooperation Intensive Care Medicine...
Abstract Background: Cholangiopathy has been described in survivors of severe COVID-19, presenting significant clinical parallels to the pre-pandemic condition secondary sclerosing cholangitis critically ill patients (SSC-CIP). Aim: Herein, we examined liver histopathology individuals with persistent cholestasis following COVID-19. Methods: Post-COVID-19 samples were subjected routine staining techniques and cytokeratin 7 immunostaining, portal parenchymal changes semi-quantitatively...
Cholangiopathy has been described in survivors of severe COVID-19, presenting significant clinical parallels to the pre-pandemic condition secondary sclerosing cholangitis critically ill patients (SSC-CIP). We aimed examine liver histopathology individuals with persistent cholestasis after COVID-19.
The prevalence of metabolic associated fatty liver disease (MAFLD) in lean patients has grown around the world and better understanding this disease, these individuals, become interest. To evaluate profile MAFLD compared to obese patients. This case-series included with from a hepatology clinic. criteria presence steatosis (ultrasound) one following clinical conditions: overweight/obesity, type 2 diabetes mellitus (T2DM), other features dysfunction. Fibrosis was evaluated by FIB4 APRI...
The spectrum of metabolic associated fatty liver disease (MAFLD) includes steatosis, steatohepatitis, that can progress to cirrhosis, hepatocellular carcinoma, and advanced stage disease. MAFLD with hepatic insufficiency has been frequent in the clinical practice. To evaluate frequency characteristics patients case-series included come from at a hepatology clinic. criteria: past or present evidence risk factors; presence previous documentation steatosis by imaging histological analysis....
Metabolic Associated Fatty Liver Disease (MAFLD) is a clinic-pathological condition commonly associated with metabolic syndrome (MS) and this association frequently found in severely obese. To compare clinical histological characteristics of MAFLD obese without MS. Cross-sectional study patients diagnosed between Sep/2014 May/2015. was by liver biopsy during bariatric surgery. MS diagnosis based on the International Diabetes Federation criteria. Statistical analyses were performed using...